Skip to content

Clinical Efficacy Observation and Safety Assessment of Acupotomy Therapy for Cervical Spondylosis-Related Neck Pain: A Randomized, Blinded, Parallel-Controlled Trial

Clinical Efficacy Observation and Safety Assessment of Acupotomy Therapy for Cervical Spondylosis-Related Neck Pain: A Randomized, Blinded, Parallel-Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000837
Enrollment
Unknown
Registered
2026-03-31
Start date
2026-04-07
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spondylosis-Related Neck Pain

Interventions

Acupotomy group:acupotomy release therapy

Sponsors

The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)Meets the diagnostic criteria for cervical spondylosis-related neck pain: The patient reports abnormal sensations such as pain in the occipital region, neck, and shoulders, which may be accompanied by corresponding tender points; imaging findings reveal degenerative changes in the cervical spine; other cervical disorders or diseases causing neck symptoms are excluded. (2) Age 18-70 years, gender unrestricted. (3) Cervical spondylosis-related neck pain with VAS score =4 (on a 0-10 scale), symptoms persisting =2 weeks but <3 months. (4) No administration of nonsteroidal anti-inflammatory drugs (NSAIDs) or muscle relaxants within the past week, and no cervical traction, massage, acupuncture, or minimally invasive treatments received within the past month. (5) Voluntarily sign the informed consent form and cooperate with the completion of treatment and 3-month follow-up. Only patients meeting all five criteria above were eligible for inclusion in this study.

Exclusion criteria

Exclusion criteria: (1) Associated with radiating pain and numbness in the upper limbs, changes in muscle strength, or gait instability in the lower limbs, or organic lesions such as cervical vertebrae fractures, dislocations, tumors, tuberculosis, or suppurative infections. (2) The patient has a history of skin lesions, infection, eczema, keloid, or skin allergy in the neck region, making needle-knife surgery inadvisable. (3) Patients with severe organic diseases (cardiac diseases such as heart failure, unstable angina, myocardial infarction; cerebrovascular diseases such as stroke, cerebral aneurysm; vascular diseases such as severe lower limb ischemia, aortic dissection, abdominal aortic aneurysm; hepatic diseases such as liver dysfunction, acute liver failure, or decompensated cirrhosis with ascites, history of esophageal and gastric variceal bleeding, hepatic encephalopathy; renal diseases such as renal insufficiency), coagulation disorders, and uncontrolled psychiatric disorders. (4) Pregnant or lactating women, or those planning to conceive during the study period. (5) Patients with allergies to needle-knife materials or lidocaine. (6) Patients with a history of cervical spine surgery or needle-knife therapy. All patients meeting any of the above criteria were excluded.

Design outcomes

Primary

MeasureTime frame
Neck Pain Visual Analogue Scale Score;

Secondary

MeasureTime frame
Neck Disability Index;Range of Motion measurement;Short Form-36 Short Form Health Survey;

Countries

China

Contacts

Public ContactFangming Liu

The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital

liufangming@sdfmu.edu.cn+86 13789823606

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026